Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumab

Inflammatory Bowel Disease

Serious infection in inflammatory bowel diseases patients treated with vedolizumab, ustekinumab, JAK inhibitors, anti-TNF or aminosalicylates

Clin Gastroenterol Hepatol

Bertrand A, Amiot A, Martin A, Carbonnel F, Meyer A

doi: 10.1016/j.cgh.2026.04.015

ColonoscopyInflammatory Bowel Disease

Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease

United European Gastroenterol J

Roblin X, Nancey S, Papamichael K, Mechi F, Ouvrier-Buffet J, Charlois AL, Peaucelle AS, Bastide L, Berger AA, Barrau M, Cheifetz AS, Duru G, Paul S

doi: 10.1002/ueg2.70207

COMMENTED

Inflammatory Bowel DiseaseFurther Publications

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

Am J Gastroenterol

Vavricka SR, Zeitz J, Madanchi M, Ruiz PA, Biedermann L, Morsy Y, Yilmaz B, Scharl M, Scharl S, Gassmann M, Lutz TA, Kunz A, Bron D, Misselwitz B, MacPherson AJ, Rogler G, Greuter T

doi: 10.14309/ajg.0000000000003888

Inflammatory Bowel Disease

Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource

Inflamm Bowel Dis

Yan K, Vuyyuru SK, Taylor A, Figueredo G, Raine T, Sanon M, Naessens D, Munje C, Moran GW

doi: 10.1093/ibd/izaf276

Inflammatory Bowel Disease

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)

Inflamm Bowel Dis

Lin SH, Kuo CJ, Chuang CH, Chang CW, Chung CS, Chou JW, Huang TY, Yen HH, Tsai TJ, Lin CP, Chang CH, Tai CM, Tai WC, Yao CC, Chen CC, Pan YB, Le PH

doi: 10.1093/ibd/izag150

Inflammatory Bowel Disease

Integration of Ustekinumab Biosimilars into Inflammatory Bowel Disease Care: Evidence, Implementation, and Patient-Centered Considerations

Adv Ther

Piche SL, Becker MD, Bhat S, Huang LL, Kane SV

doi: 10.1007/s12325-026-03584-6

Inflammatory Bowel Disease

Association of preoperative neoplasia and rectal cuff inflammation on initial pouchoscopy with subsequent neoplasia development in inflammatory bowel disease patients with an ileal pouch-anal anastomosis: a case-control study

Inflamm Bowel Dis

Powers JC, Zemanek M, Dave M, Dester E, Cates KW, Smith R, Hull T, Lavryk O, Cohen BL, Lashner B, Ivanov AI, Barnes E, Falloon K, Braga-Neto M, Qazi T

doi: 10.1093/ibd/izag112

Inflammatory Bowel Disease

Meta-analysis: safety and efficacy of ustekinumab in pediatric inflammatory bowel disease patients with anti-TNF failure

BMC Gastroenterol

Heng Z, Zhan L, Zhang Y, Xu K, Song M, Zhao K, Jahan MS, Akter MF, Lu P, Ji Y, Liu Y

doi: 10.1186/s12876-026-05078-9

Inflammatory Bowel Disease

Effectiveness and safety of vedolizumab in real-world studies in Asian patients with inflammatory bowel disease: a systematic review and meta-analysis

BMC Gastroenterol

Gu Y, Zhang X, Gu L, Zou D

doi: 10.1186/s12876-026-04975-3

Related content

Serious infection in inflammatory bowel diseases patients treated with vedolizumab, ustekinumab, JAK inhibitors, anti-TNF or aminosalicylates

Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)

Integration of Ustekinumab Biosimilars into Inflammatory Bowel Disease Care: Evidence, Implementation, and Patient-Centered Considerations

Association of preoperative neoplasia and rectal cuff inflammation on initial pouchoscopy with subsequent neoplasia development in inflammatory bowel disease patients with an ileal pouch-anal anastomosis: a case-control study

Meta-analysis: safety and efficacy of ustekinumab in pediatric inflammatory bowel disease patients with anti-TNF failure

Effectiveness and safety of vedolizumab in real-world studies in Asian patients with inflammatory bowel disease: a systematic review and meta-analysis